Precision Thyroid Hormone Therapy: Integrating Physiology, Symptoms, and Clinical Context

Abstract

Abstract
Thyroid hormone replacement remains the cornerstone of hypothyroidism management, yet a substantial subset of patients continue to experience persistent symptoms despite achieving biochemical euthyroidism with standard levothyroxine therapy. This clinical reality highlights the need for a more individualized approach to thyroid hormone replacement that accounts for interindividual variability in thyroid hormone metabolism, tissue sensitivity, and systemic physiologic context. This review proposes a clinician-focused framework for personalized thyroid hormone replacement, integrating current evidence with real-world clinical experience.
This review will examine the physiologic determinants of variability in thyroid hormone action, including deiodinase activity, hormone transport, inflammatory and metabolic influences, and the impact of age, sex hormones, and comorbid conditions. Distinct clinical phenotypes of hypothyroid patients are described to guide patient stratification and therapeutic decision-making. Therapeutic strategies are reviewed, including levothyroxine monotherapy, combination T4/T3 therapy, and alternative formulations, with emphasis on patient selection, dosing principles, and safety considerations. A practical clinical algorithm is presented to support individualized treatment adjustments based on both biochemical markers and symptom patterns.
In addition, the importance of integrating lifestyle and systemic factors-such as metabolic health, inflammation, nutrient status, and stress physiology-into comprehensive thyroid care will be discussed. Case-based examples illustrate the application of a personalized approach in common clinical scenarios. By moving beyond a one-size-fits-all model and embracing a precision framework, clinicians can better tailor thyroid hormone replacement to optimize patient outcomes. Future research priorities include phenotype-driven clinical trials and the development of biomarkers that more accurately reflect tissue-level thyroid hormone activity.